Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Department of Epidemiology and Statistics, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Spine J. 2018 Jul;18(7):1109-1115. doi: 10.1016/j.spinee.2017.10.070. Epub 2017 Nov 6.
Surgical decompression and stabilization followed by radiosurgery represents an effective method for local tumor control and neurologic preservation for patients with metastatic epidural spinal cord compression (MESCC). We have previously demonstrated improvement in health-related quality of life (HrQOL) after this combined modality treatment ("hybrid therapy").
The current analysis focuses on delineation of patient-specific prognostic factors predictive of HrQOL change after combined surgery-stereotactic radiosurgery (SRS) treatment of MESCC.
This is a prospective, single-center, cohort study.
One hundred and eleven patients with MESCC who underwent separation surgery followed by SRS were included.
Prognostic factors associated with improved patient-reported outcome (PRO) measures.
Patient-reported outcome tools, that is, Brief Pain Inventory (BPI) and MD Anderson Symptom Inventory-Spine Tumor (MDASI-SP), both validated in the cancer population, were prospectively collected. Numeric prognostic factors were correlated with PRO measures using the Spearman rank correlation coefficient. Categorical prognostic factors were correlated with PRO measures using the Wilcoxon two-sample test (for two categories) or the Kruskal-Wallis test (for three or more categories). All statistical tests were two-sided with a level of significance <.05 for correlation of prognostic factors with PRO constructs and a level of significance <.0014 for correlation of prognostic factors with PRO items. Statistical analyses were done in SAS (version 9.4, Cary, NC, USA).
One hundred and eleven patients were included in this analysis. Patients with lower preoperative Medical Research Council (MRC) motor scores experienced a greater decrease in symptom interference (BPI interference construct (p=.03) and individual functional measures including general activity (p=.001), walking (p=.001), and normal work (p=.006)). Lumbar location was associated with better outcomes than cervical or thoracic as noted on the BPI pain experience construct (p=.03) and MDASI-SP interference (p=.01) and core symptom (p=.002) constructs. Patients with American Spinal Injury Association (ASIA) scores of C or D benefit more than those with ASIA E on BPI interference construct (p=.04). Patients with higher Eastern Cooperative Oncology Group (ECOG) scores at presentation benefit more than those with low ECOG scores on MDASI-SP interference construct (p=.03). Women benefit more than men on BPI interference (p=.03) and pain experience (p=.04) constructs. Patients with prior spinal surgery at the current level of interest benefit less than those who are naïve surgical patients in MDASI-SP interference construct (p=.04).
Delineation of patient characteristics associated with HrQOL improvement provides crucial information for patient selection, patient education, and setting treatment expectations. For patients with MESCC treated with hybrid therapy using surgery and radiosurgery, the presence of neurologic deficits and diminished performance status, lumbar tumor level, and female gender were associated with greater PRO improvement.
手术减压和稳定后行放射外科手术代表了一种有效的局部肿瘤控制和神经保存方法,适用于转移性硬膜外脊髓压迫症(MESCC)患者。我们之前已经证明了这种联合治疗方法(“混合疗法”)后健康相关生活质量(HrQOL)的改善。
目前的分析重点是确定与 MESCC 患者接受联合手术-立体定向放射外科(SRS)治疗后 HrQOL 变化相关的患者特异性预后因素。
这是一项前瞻性、单中心、队列研究。
111 例接受过分离手术并随后接受 SRS 的 MESCC 患者被纳入研究。
与患者报告的结局(PRO)测量改善相关的预后因素。
前瞻性收集经验证可用于癌症患者的患者报告结局工具,即简要疼痛量表(BPI)和 MD 安德森症状量表-脊柱肿瘤(MDASI-SP)。使用 Spearman 秩相关系数将数字预后因素与 PRO 测量相关联。使用 Wilcoxon 两样本检验(对于两个类别)或 Kruskal-Wallis 检验(对于三个或更多类别)将分类预后因素与 PRO 测量相关联。所有统计检验均为双侧检验,与 PRO 结构相关的预后因素的显著性水平<.05,与 PRO 项目相关的预后因素的显著性水平<.0014。统计分析在 SAS(版本 9.4,美国北卡罗来纳州卡里)中进行。
本分析共纳入 111 例患者。术前医疗研究委员会(MRC)运动评分较低的患者在症状干扰方面的下降更大(BPI 干扰结构(p=.03)和包括一般活动(p=.001)、行走(p=.001)和正常工作(p=.006)在内的个体功能测量)。与颈或胸段相比,腰椎部位在 BPI 疼痛体验结构(p=.03)和 MDASI-SP 干扰(p=.01)和核心症状(p=.002)结构方面与更好的结果相关。美国脊髓损伤协会(ASIA)评分 C 或 D 的患者比 ASIA E 的患者在 BPI 干扰结构上获益更多(p=.04)。就诊时 ECOG 评分较高的患者比 ECOG 评分较低的患者在 MDASI-SP 干扰结构上获益更多(p=.03)。女性在 BPI 干扰(p=.03)和疼痛体验(p=.04)结构方面比男性获益更多。在当前感兴趣的水平上有过脊柱手术的患者比没有接受过手术的患者在 MDASI-SP 干扰结构上获益较少(p=.04)。
确定与 HrQOL 改善相关的患者特征可为患者选择、患者教育和设定治疗预期提供关键信息。对于接受手术和放射外科手术联合治疗的 MESCC 患者,神经功能缺陷和活动能力下降、腰椎肿瘤水平和女性性别与 PRO 改善更大相关。